Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Escherichia coli

ABSTRACT: ESBL-producing E. coli among gut-colonized children in Peru

PROVIDER: PRJNA821865 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR18593200_1.fastq.gz	Fastqsanger.gz
	SRR18593200_2.fastq.gz	Fastqsanger.gz
	SRR18593201_1.fastq.gz	Fastqsanger.gz
	SRR18593201_2.fastq.gz	Fastqsanger.gz
	SRR18593202_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 156

Similar Datasets

Escherichia coli

Project description:ESBL producing Escherichia coli

| PRJNA554638 | ENA

Escherichia coli

Project description:Complete nucleotide sequences of ESBL-producing E. coli recovered from food and healthy, gut-colonized humans in Cambodia

| PRJNA566431 | ENA

Transcriptional alterations of virulence-associated genes in extended spectrum beta-lactamase (ESBL)-producing uropathogenic Escherichia coli during morphologic transitions induced by ineffective antibiotics

Project description:The present study examines changes in global gene expression patterns and in virulence factor-associated genes in an extended spectrum beta-lactamase (ESBL)-producing UPEC (ESBL019) during the morphologic transitions induced by an ineffective antibiotic and in the presence of human primary bladder epithelial cells. The morphological shifts induced by ineffective antibiotics are associated with significant transcriptional virulence alterations in ESBL-producing UPEC, which may affect survival and persistence in the urinary tract.

2017-06-06 | GSE99661 | GEO

RNAseq transcriptome analysis of K. pneumoniae MS6671 and E. coli MS8345 treated with PBT2

Project description:The emergence of colistin resistance in carbapenem-resistant and extended-spectrum ß-lactamase (ESBL)-producing bacteria is a significant threat to human health, and new treatment strategies are urgently required. Here we investigated the ability of the safe-for-human use ionophore PBT2 to restore antibiotic sensitivity in several polymyxin-resistant, ESBL-producing, carbapenem resistant Gram-negative human pathogens. PBT2 was observed to resensitize Klebsiella pneumoniae, Escherichia coli, Acinetobacter baumannii, and Pseudomonas aeruginosa to last-resort polymyxin class antibiotics, including a ‘next generation’ polymyxin derivative, FADDI-287. To gain additional insight into the potential mechanism of action of PBT2, we analyzed the transcriptome of K. pneumoniae and E. coli in the presence of sub-inhibitory concentrations of PBT2. Treatment with PBT2 was associated with multiple stress responses in both K. pneumoniae and E. coli. Significant changes in the transcription of transition metal ion homeostasis genes were observed in both strains.

2019-06-13 | GSE132637 | GEO

Escherichia coli

Project description:ESBL producing E. coli isolated from waterways

| PRJNA669884 | ENA

Escherichia coli

Project description:ESBL-producing Escherichia coli Raw sequence reads

| PRJNA1077717 | ENA

Escherichia coli strain:V282

Project description:WGS of ESBL producing E. coli

| PRJNA300618 | ENA

Escherichia coli

Project description:Within-host diversity of ESBL-producing Escherichia coli